Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Alex Mutebi, Anthony Wang, Jonathon Brett Cohen, Sabarish Ayyappan et al.
Citations
3 citations
Journal
Clinical Lymphoma Myeloma & Leukemia
Topics
Lymphoma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
1.27
article
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Alex Mutebi, Anthony Wang, Jonathon Brett Cohen, Sabarish Ayyappan, Melissa A. Larson, Sara Haddadi, Anupama Kalsekar, Thomas Matthew Habermann, Lynn Huynh, Rajesh Kamalakar, Loretta J. Nastoupil, Peter Martin, Izidore S. Lossos, Monika Jun, Ruitao Lin, Dai Chihara, Matthew J. Maurer, Chi Gao, Tongsheng Wang, Mei Sheng Duh, Amy A. Ayers, Carla Casulo, Michele Stanchina, Brad S. Kahl, James R. Cerhan, Clark R. Andersen, Christopher R. Flowers, Brian K. Link, Jean Louise Koff, Ziyi Li, Yucai Wang, Ramya Ramasubramanian
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Lymphoma Myeloma & LeukemiaVol. 25(4)
Institutions
University of Iowa (US), The University of Texas MD Anderson Cancer Center (US), University of Miami (US), Emory University (US), Washington University in St. Louis (US), Cornell University (US), Genmab (United States) (US), University of Rochester Medical Center (US), AbbVie (United States) (US), University of Miami Health System (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), Analysis Group (United States) (US)
Funders
Cancer Prevention and Research Institute of Texas, National Cancer Institute